Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung

References

• Agustí A, Hogg J. 2019. Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med. 381(13):1248–1256.
   PubMed Web of Science ®Google Scholar
• Allard B, Panariti A, Martin J. 2018. Alveolar macrophages in the resolution of inflammation, tissue repair, and tolerance to infection. Front Immunol. 9:1777.
   PubMed Web of Science ®Google Scholar
• Alton E, Stern M, Farley R, Jaffe A, Chadwick S, Phillips J, Davies J, Smith S, Browning J, Davies M, et al. 1999. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial. Lancet. 353(9157):947–954.
   PubMed Web of Science ®Google Scholar
• Andon F, Digifico E, Maeda A, Erreni M, Mantovani A, Alonso M, Allavena P. 2017. Targeting tumor-associated macrophages: The new challenge for nanomedicine. Semin Immunol. 34:103–113.
   PubMed Web of Science ®Google Scholar
• Bao Y, Jin Y, Chivukula P, Zhang J, Liu Y, Liu J, Clamme J, Mahato R, Ng D, Ying W, et al. 2013. Effect of PEGylation on biodistribution and gene silencing of siRNA/Lipid nanoparticle complexes. Pharm Res. 30(2):342–351.
   PubMed Web of Science ®Google Scholar
• Barillet S, Fattal E, Mura S, Tsapis N, Pallardy M, Hillaireau H, Kerdine-Römer S. 2019. Immunotoxicity of poly (lactic-co-glycolic acid) nanoparticles: Influence of surface properties on dendritic cell activation. Nanotoxicology. 13(5):606–622.
   PubMed Web of Science ®Google Scholar
• Barnes P, Burney P, Silverman E, Celli B, Vestbo J, Wedzicha J, Wouters E. 2015. Chronic obstructive pulmonary disease. Nat. Rev. Dis. Primers. 1:15076.
   PubMed Web of Science ®Google Scholar
• Barnes P, Stockley R. 2005. COPD: Current therapeutic interventions and future approaches. Eur Respir J. 25(6):1084–1106.
   PubMed Web of Science ®Google Scholar
• Belchamber K, Donnelly L. 2017. Macrophages, origin, functions and biointervention. Results Probl. Cell Differ. 62:299–313.
   PubMedGoogle Scholar
• Belliveau N, Huft J, Lin P, Chen S, Leung A, Leaver T, Wild A, Lee J, Taylor R, Tam Y, et al. 2012. Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA. Mol. Ther. Nucl. Acids. 1:e37.
   Google Scholar
• Bhardwaj A, Mehta S, Yadav S, Singh S, Grobler A, Goyal A, Mehta A. 2015. Pulmonary delivery of anti-tubercular drugs using spray-dried lipid-polymer hybrid nanoparticles. Artif. Cells Nanomed. Biotechnol. 44:1–12.
   Web of Science ®Google Scholar
• Boraschi D, Italiani P, Palomba R, Decuzzi P, Duschl A, Fadeel B, Moghimi S. 2017. Nanoparticles and innate immunity: New perspectives on host defence. Semin Immunol. 34:33–51.
   PubMed Web of Science ®Google Scholar
• Borghardt J, Kloft C, Sharma A. 2018. Inhaled therapy in respiratory disease: The complex interplay of pulmonary kinetic processes. Can. Respir. J. 2018:1–11.
   Web of Science ®Google Scholar
• Braakhuis H, Park M, Gosens I, de Jong W, Cassee F. 2014. Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol. 11:18
   PubMed Web of Science ®Google Scholar
• Buck J, Grossen P, Cullis P, Huwyler J, Witzigmann D. 2019. Lipid-based DNA therapeutics: Hallmarks of non-viral gene delivery. ACS Nano. 13(4):3754–3782.
   PubMed Web of Science ®Google Scholar
• Bus T, Traeger A, Schubert U. 2018. The great escape: How cationic polyplexes overcome the endosomal barrier. J Mater Chem B. 6(43):6904–6918.
   PubMed Web of Science ®Google Scholar
• Canonico A, Conary J, Meyrick B, Brigham K. 1994. Aerosol and intravenous transfection of human α1-antitrypsin gene to lungs of rabbits. Am J Respir Cell Mol Biol. 10(1):24–29.
   PubMed Web of Science ®Google Scholar
• Celli B, Wedzicha J. 2019. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med. 381(13):1257–1266.
   PubMed Web of Science ®Google Scholar
• Champion J, Mitragotri S. 2009. Shape induced inhibition of phagocytosis of polymer particles. Pharm Res. 26(1):244–249.
   PubMed Web of Science ®Google Scholar
• Chan C, Majzoub R, Shirazi R, Ewert K, Chen Y, Liang K, Safinya C. 2012. Endosomal escape and transfection efficiency of PEGylated cationic liposome-DNA complexes prepared with an acid-labile PEG-lipid. Biomaterials. 33(19):4928–4935.
   PubMed Web of Science ®Google Scholar
• Chen J, Guan X, Hu Y, Tian H, Chen X. 2017. Peptide-based and polypeptide-based gene delivery systems. Top Curr Chem (Cham)). 375(2):32
   PubMed Web of Science ®Google Scholar
• Chen S, Tam Y, Lin P, Sung M, Tam Y, Cullis P. 2016. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA. J Control Release. 235:236–244.
   PubMed Web of Science ®Google Scholar
• Cho C. 2012. Design and development of degradable polyethylenimines for delivery of DNA and small interfering RNA: An updated review. ISRN Mater. Sci. 2012:1–24.
   Google Scholar
• Choi M, Gu J, Lee M, Rhim T. 2017. A new combination therapy for asthma using dual-function dexamethasone-conjugated polyethylenimine and Vitamin D binding protein siRNA. Gene Ther. 24(11):727–734.
   PubMed Web of Science ®Google Scholar
• Costa A, Sarmento B, Seabra V. 2015. Targeted drug delivery systems for lung macrophages. Curr Drug Targets. 16(14):1565–1581.
   PubMed Web of Science ®Google Scholar
• Costa A, Sarmento B, Seabra V. 2018. Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages. Eur J Pharm Sci. 114:103–113.
   PubMed Web of Science ®Google Scholar
• Cullis P, Hope M. 2017. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 25(7):1467–1475.
   PubMed Web of Science ®Google Scholar
• Dan N, Danino D. 2014. Structure and kinetics of lipid-nucleic acid complexes. Adv Colloid Interface Sci. 205:230–239.
   PubMed Web of Science ®Google Scholar
• Dasa S, Suzuki R, Mugler E, Chen L, Jansson-Lofmark R, Michaelsson E, Lindfors L, Klibanov A, French B, Kelly K. 2017. Evaluation of pharmacokinetic and pharmacodynamic profiles of liposomes for the cell type-specific delivery of small molecule drugs. Nanomedicine. 13(8):2565–2574.
   PubMed Web of Science ®Google Scholar
• Desch A, Gibbings S, Goyal R, Kolde R, Bednarek J, Bruno T, Slansky J, Jacobelli J, Mason R, Ito Y, et al. 2016. Flow cytometric analysis of mononuclear phagocytes in non-diseased human lung and lung-draining lymph nodes. Am J Respir Crit Care Med. 193(6):614–626.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia M, Shurin M, Shvedova A. 2016. Current understanding of interactions between nanoparticles and the immune system. Toxicol Appl Pharmacol. 299:78–89.
   PubMed Web of Science ®Google Scholar
• Doshi N, Mitragotri S. 2010. Macrophages recognize size and shape of their targets. Plos One. 5(4):e10051
   PubMedGoogle Scholar
• Dowdy S. 2017. Overcoming cellular barriers for RNA therapeutics. Nat Biotechnol. 35(3):222–229.
   PubMed Web of Science ®Google Scholar
• Dua K, Wadhwa R, Singhvi G, Rapalli V, Shukla S, Shastri M, Gupta G, Satija S, Mehta M, Khurana N, et al. 2019. The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress. Drug Dev Res. 80(6):714–730.
   PubMed Web of Science ®Google Scholar
• El-Sherbiny I, El-Baz N, Yacoub M. 2015. Inhaled nano- and microparticles for drug delivery. Global Cardiol. Sci. Pract. 2015(1):2.
   Google Scholar
• Evren E, Ringqvist E, Willinger T. 2020. Origin and ontogeny of lung macrophages: From mice to humans. Immunology. 160(2):126–138.
   PubMed Web of Science ®Google Scholar
• Fabre J, Collins L. 2006. Synthetic peptides as non-viral DNA Vectors. Curr Gene Ther. 6(4):459–480.
   PubMed Web of Science ®Google Scholar
• Fadeel B. 2019. Hide and seek: Nanomaterial interactions with the immune system. Front Immunol. 10:133
   PubMed Web of Science ®Google Scholar
• Fang R, Hu C, Zhang L. 2012. Nanoparticles disguised as red blood cells to evade the immune system. Expert Opin Biol Ther. 12(4):385–389.
   PubMed Web of Science ®Google Scholar
• Frohlich E, Salar-Behzadi S. 2014. Toxicological assessment of inhaled nanoparticles: Role of in vivo, ex vivo, in vitro, and in silico studies. Int J Mol Sci. 15(3):4795–4822.
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Velichko S, Thai P, Hung L, Huang F, Wu R. 2009. Regulation of airway MUC5AC expression by IL-1β and IL-17a: The NF-κB paradigm. J Immunol. 183(10):6236–6624.
   PubMed Web of Science ®Google Scholar
• Galbiati V, Papale A, Kummer E, Corsini E. 2016. In vitro models to evaluate drug-induced hypersensitivity: Potential test based on Activation of Dendritic Cells. Front Pharmacol. 7:204
   PubMed Web of Science ®Google Scholar
• Garbi N, Lambrecht B. 2017. Location, function, and ontogeny of pulmonary macrophages during the steady state. Pflugers Arch. 469(3-4):561–572.
   PubMed Web of Science ®Google Scholar
• Garbuzenko O, Ivanova V, Kholodovych V, Reimer D, Reuhl K, Yurkow E, Adler D, Minko T. 2017. Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s). Nanomedicine. 13(6):1983–1992.
   PubMed Web of Science ®Google Scholar
• Garbuzenko O, Saad M, Pozharov V, Reuhl K, Mainelis G, Minko T. 2010. Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance. Proc Natl Acad Sci U S A. 107(23):10737–10742.
   PubMed Web of Science ®Google Scholar
• Geiser M. 2010. Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv. 23(4):207–217.
   PubMed Web of Science ®Google Scholar
• Getts D, Shea L, Miller S, King N. 2015. Harnessing nanoparticles for immune modulation. Trends Immunol. 36(7):419–427.
   PubMed Web of Science ®Google Scholar
• Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U, Manygoats K, Seifert S, Andree C, Stoter M, et al. 2013. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat Biotechnol. 31(7):638–646.
   PubMed Web of Science ®Google Scholar
• Grabiec A, Hussell T. 2016. The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammation. Semin Immunopathol. 38(4):409–423.
   PubMed Web of Science ®Google Scholar
• Grant E, Thomas M, Fortune J, Klibanov A, Letvin N. 2012. Enhancement of plasmid DNA immunogenicity with linear polyethylenimine. Eur J Immunol. 42(11):2937–2948.
   PubMed Web of Science ®Google Scholar
• Green R, Brightling C, Pavord I, Wardlaw A. 2003. Management of asthma in adults: Current therapy and future directions. Postgrad Med J. 79(931):259–267.
   PubMed Web of Science ®Google Scholar
• Guan S, Munder A, Hedtfeld S, Braubach P, Glage S, Zhang L, Lienenklaus S, Schultze A, Hasenpusch G, Garrels W, et al. 2019. Self-assembled peptide-poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis. Nat Nanotechnol. 14(3):287–297.
   PubMed Web of Science ®Google Scholar
• Gustafson H, Holt-Casper D, Grainger D, Ghandehari H. 2015. Nanoparticle uptake: The phagocyte problem. Nano Today. 10(4):487–510.
   PubMed Web of Science ®Google Scholar
• Hafez I, Maurer N, Cullis P. 2001. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther. 8(15):1188–1196.
   PubMed Web of Science ®Google Scholar
• Hayes A, Bakand S. 2014. Toxicological perspectives of inhaled therapeutics and nanoparticles. Expert Opin Drug Metab Toxicol. 10(7):933–947.
   PubMed Web of Science ®Google Scholar
• He Y, Liang Y, Han R, Lu W, Mak J, Zheng Y. 2019. Rational particle design to overcome pulmonary barriers for obstructive lung diseases therapy. J Control Release. 314:48–61.
   PubMed Web of Science ®Google Scholar
• Heukels P, Moor C, Thüsen J, Wijsenbeek M, Kool M. 2019. Inflammation and immunity in IPF pathogenesis and treatment. Respir Med. 147:79–91.
   PubMed Web of Science ®Google Scholar
• Hirota K, Terada H. 2012. Endocytosis of particle formulations by macrophages and its application to clinical treatment. In: Ceresa B, editor. Molecular regulation of endocytosis. Rijeka: InTechOpen.
   Google Scholar
• Hogan SP, Foster PS, Tan X, Ramsay AJ. 1998. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur J Immunol. 28(2):413–423.
   PubMed Web of Science ®Google Scholar
• Hoshyar N, Gray S, Han H, Bao G. 2016. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine (Lond)). 11(6):673–692.
   PubMed Web of Science ®Google Scholar
• Hu C, Zhang L, Aryal S, Cheung C, Fang R, Zhang L. 2011. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A. 108(27):10980–10985.
   PubMed Web of Science ®Google Scholar
• Huang X, Schwind S, Yu B, Santhanam R, Wang H, Hoellerbauer P, Mims A, Klisovic R, Walker AR, Chan KK, et al. 2013. Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: A novel therapeutic strategy in acute myeloid leukemia. Clin Cancer Res. 19(9):2355–2367.
   PubMed Web of Science ®Google Scholar
• Hussell T, Bell T. 2014. Alveolar macrophages: Plasticity in a tissue-specific context. Nat Rev Immunol. 14(2):81–93.
   PubMed Web of Science ®Google Scholar
• Hwang T, Aljuffali I, Hung C, Chen C, Fang J. 2015. The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs). Chem Biol Interact. 235:106–114.
   PubMed Web of Science ®Google Scholar
• Ishida T, Ichihara M, Wang X, Yamamoto K, Kimura J, Majima E, Kiwada H. 2006. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J Control Release. 112(1):15–25.
   PubMed Web of Science ®Google Scholar
• Jayaraman M, Ansell SM, Mui BL, Tam YK, Chen J, Du X, Butler D, Eltepu L, Matsuda S, Narayanannair JK, et al. 2012. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem Int Ed Engl. 51(34):8529–8533.
   PubMed Web of Science ®Google Scholar
• Jensen D, Jensen L, Koocheki S, Bengtson L, Cun D, Nielsen H, Foged C. 2012. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. J Control Release. 157(1):141–148.
   PubMed Web of Science ®Google Scholar
• Jesus M, Zuhorn I. 2015. Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanisms. J Control Release. 201:1–13.
   PubMed Web of Science ®Google Scholar
• Jin H, Kim T, Hwang S, Chang S, Kim H, Anderson H, Lee H, Lee K, Colburn N, Yang H, et al. 2006. Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol Cancer Ther. 5(4):1041–1049.
   PubMed Web of Science ®Google Scholar
• Jorge A, Pais A, Vitorino C. 2019. Drug delivery systems. Meth. Mol. Biol. 2059:259–283.
   Google Scholar
• Jubrail J, Kurian N, Niedergang F. 2017. Macrophage phagocytosis cracking the defect code in COPD. Biomed J. 40(6):305–312.
   PubMed Web of Science ®Google Scholar
• Kang Z, Meng Q, Liu K. 2019. Peptide-based gene delivery vectors. J Mater Chem B. 7(11):1824–1841.
   PubMed Web of Science ®Google Scholar
• Khongkow M, Yata T, Boonrungsiman S, Ruktanonchai UR, Graham D, Namdee K. 2019. Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood-brain barrier penetration. Sci Rep. 9(1):8278
   PubMedGoogle Scholar
• Kolahian S, Fernandez I, Eickelberg O, Hartl D. 2016. Immune mechanisms in pulmonary fibrosis. Am J Respir Cell Mol Biol. 55(3):309–322.
   PubMed Web of Science ®Google Scholar
• Konduru NV, Molina RM, Swami A, Damiani F, Pyrgiotakis G, Lin P, Andreozzi P, Donaghey TC, Demokritou P, Krol S, et al. 2017. Protein corona: Implications for nanoparticle interactions with pulmonary cells. Part Fibre Toxicol. 14(1):42
   PubMedGoogle Scholar
• Kong X, Hellermann G, Zhang W, Jena P, Kumar M, Behera A, Behera S, Lockey R, Mohapatra S. 2008. Chitosan interferon-gamma nanogene therapy for lung disease: Modulation of T-cell and dendritic cell immune responses. Allergy Asthma Clin Immunol. 4(3):95–105.
   PubMedGoogle Scholar
• Kononenko V, Narat M, Drobne D. 2015. Nanoparticle interaction with the immune system. Arh Hig Rada Toksikol. 66(2):97–108.
   PubMed Web of Science ®Google Scholar
• Koppolu B, Zaharoff D. 2013. The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells. Biomaterials. 34(9):2359–2369.
   PubMed Web of Science ®Google Scholar
• Kormann M, Hasenpusch G, Aneja M, Nica G, Flemmer A, Herber-Jonat S, Huppmann M, Mays L, Illenyi M, Scham A, et al. 2011. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol. 29(2):154–157.
   PubMed Web of Science ®Google Scholar
• Kristen A, Ajroud-Driss S, Conceição I, Gorevic P, Kyriakides T, Obici L. 2019. Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis. Neurodegener Dis Manag. 9(1):5–23.
   PubMed Web of Science ®Google Scholar
• Kulkarni J, Cullis P, Meel R. 2018. Lipid nanoparticles enabling gene therapies: From concepts to clinical utility. Nucleic Acid Ther. 28(3):146–157.
   PubMed Web of Science ®Google Scholar
• Kumar M, Kong X, Behera A, Hellermann G, Lockey R, Mohapatra S. 2003. Chitosan IFNγ-pDNA nanoparticle (CIN) therapy for allergic asthma. Genet Vaccines Ther. 1(1):3
   PubMedGoogle Scholar
• Lam J, Liang W, Chan H. 2012. Pulmonary delivery of therapeutic siRNA. Adv Drug Deliv Rev. 64(1):1–15.
   PubMed Web of Science ®Google Scholar
• Lambrecht B, Hammad H. 2012a. Lung dendritic cells in respiratory viral infection and asthma: From protection to immunopathology. Annu Rev Immunol. 30:243–270.
   PubMed Web of Science ®Google Scholar
• Lambrecht B, Hammad H. 2012b. The airway epithelium in asthma. Nat Med. 18(5):684–692.
   PubMed Web of Science ®Google Scholar
• Lambrecht B, Hammad H. 2014. Dendritic cell and epithelial cell interactions at the origin of murine asthma. Annals Ats. 11(Supplement 5):S236–S243.
   Google Scholar
• Lambrecht B, Hammad H, Fahy J. 2019. The cytokines of asthma. Immunity. 50(4):975–991.
   PubMed Web of Science ®Google Scholar
• Lambrecht B, Persson E, Hammad H. 2017. Myeloid cells in asthma. Microbiol. Spectr. 5:1–17.
   Web of Science ®Google Scholar
• Laouini A, Andrieu V, Vecellio L, Fessi H, Charcosset C. 2014. Characterization of different Vitamin E carriers intended for pulmonary drug delivery. Intl. J. Pharm. 471(1-2):385–390.
   PubMed Web of Science ®Google Scholar
• Lee W, Loo C, Traini D, Young P. 2015. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages. Expert Opin Drug Deliv. 12(6):1009–1026.
   PubMed Web of Science ®Google Scholar
• Levine R, Pearce T, Adil M, Kokkoli E. 2013. Preparation and characterization of liposome-encapsulated plasmid DNA for gene delivery. Langmuir. 29(29):9208–9215.
   PubMed Web of Science ®Google Scholar
• Li G, Jin F, Du J, He Q, Yang B, Luo P. 2019. Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis. Toxicol Appl Pharmacol. 366:10–16.
   PubMed Web of Science ®Google Scholar
• Lin M, Lin C, Yang S, Hung C, Fang J. 2018. The interplay between nanoparticles and neutrophils. J Biomed Nanotechnol. 14(1):66–85.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hardie J, Zhang X, Rotello V. 2017. Effects of engineered nanoparticles on the innate immune system. Semin Immunol. 34:25–32.
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang W, Li Y, Chang J, Tian F, Zhao F, Ma Y, Sun J. 2019. Microfluidic sonication to assemble exosome membrane-coated nanoparticles for immune evasion-mediated targeting. Nano Lett. 19(11):7836–7844.
   PubMed Web of Science ®Google Scholar
• Lonez C, Vandenbranden M, Ruysschaert J. 2012. Cationic lipids activate intracellular signaling pathways. Adv Drug Deliv Rev. 64(15):1749–1758.
   PubMed Web of Science ®Google Scholar
• Loughran S, McRudden C, McCarthy H. 2015. Designer peptide delivery systems for gene therapy. Eur. J. Nanomed. 7:85–96.
   Web of Science ®Google Scholar
• Mager I, Eiríksdottir E, Langel K, Andaloussi S, Langel U. 2010. Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assay. Biochim Biophys Acta. 1798(3):338–343.
   PubMed Web of Science ®Google Scholar
• Mangal S, Gao W, Li T, Zhou Q. 2017. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: Challenges and opportunities. Acta Pharmacol Sin. 38(6):782–797.
   PubMed Web of Science ®Google Scholar
• Mann A, Thakur G, Shukla V, Ganguli M. 2008. Peptides in DNA delivery: Current insights and future directions. Drug Discov Today. 13(3-4):152–160.
   PubMed Web of Science ®Google Scholar
• Mansour H, Haemosu H, Wu X. 2009. Nanomedicine in pulmonary delivery. Intl. J. Nanomed. 4:299–319.
   PubMed Web of Science ®Google Scholar
• Maretti E, Costantino L, Rustichelli C, Leo E, Croce M, Buttini F, Truzzi E, Iannuccelli V. 2017. Surface engineering of solid lipid nanoparticle assemblies by methyl α-D-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy. Int J Pharm. 528(1-2):440–451.
   PubMedGoogle Scholar
• Martin M, Rice K. 2007. Peptide-guided gene delivery. AAPS J. 9(1):E18–29.
   PubMed Web of Science ®Google Scholar
• Mastorakos P, da Silva A, Chisholm J, Song E, Choi W, Boyle M, Morales M, Hanes J, Suk J. 2015. Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy. Proc Natl Acad Sci U S A. 112(28):8720–8725.
   PubMed Web of Science ®Google Scholar
• Mathie S, Dixon K, Walker S, Tyrrell V, Mondhe M, O'Donnell V, Gregory L, Lloyd C. 2015. Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challenge. Allergy. 70(1):80–89.
   PubMed Web of Science ®Google Scholar
• Maugeri M, Nawaz M, Papadimitriou A, Angerfors A, Camponeschi A, Na M, Holtta M, Skantze P, Johansson S, Sundqvist M, et al. 2019. Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells. Nat Commun. 10(1):4333
   PubMed Web of Science ®Google Scholar
• McErlean E, McCrudden C, McCarthy H. 2015. Multifunctional delivery systems for cancer gene therapy. In: Hashad D, editors. Gene therapy – principles and challenges. Rijeka: InTechOpen.
   Google Scholar
• Merkel O, Kissel T. 2012. Nonviral pulmonary delivery of siRNA. Acc Chem Res. 45(7):961–970.
   PubMed Web of Science ®Google Scholar
• Merkel O, Rubinstein I, Kissel T. 2014. siRNA delivery to the lung: What's new? Adv Drug Deliv Rev. 75:112–128.
   PubMed Web of Science ®Google Scholar
• Merkel O, Zheng M, Debus H, Kissel T. 2012. Pulmonary gene delivery using polymeric nonviral vectors. Bioconjug Chem. 23(1):3–20.
   PubMed Web of Science ®Google Scholar
• Moghimi S, Szebeni J. 2003. Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res. 42(6):463–478.
   PubMed Web of Science ®Google Scholar
• Mohamed A, Kunda N, Ross K, Hutcheon G, Saleem I. 2019. Polymeric nanoparticles for the delivery of miRNA to treat chronic obstructive pulmonary disease (COPD). Eur J Pharm Biopharm. 136:1–8.
   PubMed Web of Science ®Google Scholar
• Molinaro R, Corbo C, Martinez JO, Taraballi F, Evangelopoulos M, Minardi S, Yazdi IK, Zhao P, De Rosa E, Sherman MB, et al. 2016. Biomimetic proteolipid vesicles for targeting inflamed tissues. Nat Mater. 15(9):1037–1046.
   PubMed Web of Science ®Google Scholar
• Moreno-Sastre M, Pastor M, Salomon C, Esquisabel A, Pedraz J. 2015. Pulmonary drug delivery: A review on nanocarriers for antibacterial chemotherapy. J Antimicrob Chemother. 70(11):2945–2955.
   PubMed Web of Science ®Google Scholar
• Muhammad Q, Jang Y, Kang S, Moon J, Kim W, Park H. 2020. Modulation of immune responses with nanoparticles and reduction of their immunotoxicity. Biomater Sci. 8(6):1490–1501.
   PubMed Web of Science ®Google Scholar
• Muhlfeld C, Rothen-Rutishauser B, Blank F, Vanhecke D, Ochs M, Gehr P. 2008. Interactions of nanoparticles with pulmonary structures and cellular responses. Am J Physiol. 294:L817–829.
   PubMed Web of Science ®Google Scholar
• Nakagome K, Okunishi K, Imamura M, Harada H, Matsumoto T, Tanaka R, Miyazaki J, Yamamoto K, Dohi M. 2009. IFNγ attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine. J Immunol. 183(1):209–220.
   PubMed Web of Science ®Google Scholar
• Nanjwade B, Adichwal S, Gaikwad K, Parikh K, Manvi F. 2011. Pulmonary drug delivery: Novel pharmaceutical technologies breathe new life into the lungs. PDA J Pharm Sci Technol. 65(5):513–534.
   PubMedGoogle Scholar
• Nayerossadat N, Maedeh T, Ali P. 2012. Viral and nonviral delivery systems for gene delivery. Adv Biomed Res. 1:27
   PubMedGoogle Scholar
• Ngan C, Asmawi A. 2018. Lipid-based pulmonary delivery system: A review and future considerations of formulation strategies and limitations. Drug Deliv Transl Res. 8(5):1527–1544.
   PubMed Web of Science ®Google Scholar
• Omidi Y, Barar J, Heidari H, Ahmadian S, Yazdi H, Akhtar S. 2008. Microarray analysis of the toxicogenomics and the genotoxic potential of a cationic lipid-based gene delivery nanosystem in human alveolar epithelial A549 cells. Toxicol Mech Methods. 18(4):369–378.
   PubMed Web of Science ®Google Scholar
• Pakunlu R, Wang Y, Tsao W, Pozharov V, Cook T, Minko T. 2004. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: Novel multicomponent delivery system. Cancer Res. 64(17):6214–6224.
   PubMed Web of Science ®Google Scholar
• Paranjpe M, Müller-Goymann C. 2014. Nanoparticle-mediated pulmonary drug delivery: A review. Int J Mol Sci. 15(4):5852–5873.
   PubMed Web of Science ®Google Scholar
• Patel S, Ashwanikumar N, Robinson E, DuRoss A, Sun C, Murphy-Benenato KE, Mihai C, Almarsson Ö, Sahay G. 2017. Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA. Nano Lett. 17(9):5711–5718.
   PubMed Web of Science ®Google Scholar
• Patel B, Gupta N, Ahsan F. 2015. Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome. Eur J Pharm Biopharm. 89:163–174.
   PubMed Web of Science ®Google Scholar
• Patel A, Kaczmarek J, Bose S, Kauffman K, Mir F, Heartlein M, de Rosa F, Langer R, Anderson D. 2019. Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium. Adv Mater. 31(8):e1805116
   PubMed Web of Science ®Google Scholar
• Pozo-Rodríguez A, Solinís M, Gascón A, Pedraz J. 2009. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm. 71(2):181–189.
   PubMed Web of Science ®Google Scholar
• Pozo-Rodríguez A, Solinís M, Rodríguez-Gascón A. 2016. Applications of lipid nanoparticles in gene therapy. Eur J Pharm Biopharm. 109:184–193.
   PubMed Web of Science ®Google Scholar
• Qie Y, Yuan H, von Roemeling C, Chen Y, Liu X, Shih K, Knight J, Tun H, Wharen R, Jiang W, et al. 2016. Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes. Sci Rep. 6:26269
   PubMed Web of Science ®Google Scholar
• Regnstrom K, Ragnarsson EG, Köping-Hoggard M, Torstensson E, Nyblom H, Artursson P. 2003. PEI - a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice. Gene Ther. 10(18):1575–1583.
   PubMed Web of Science ®Google Scholar
• Rehman Z, Zuhorn I, Hoekstra D. 2013. How cationic lipids transfer nucleic acids into cells and across cellular membranes: Recent advances. J Control Release. 166(1):46–56.
   PubMed Web of Science ®Google Scholar
• Robinson E, MacDonald K, Slaughter K, McKinney M, Patel S, Sun C, Sahay G. 2018. Lipid nanoparticle-delivered chemically-modified mRNA restores chloride secretion in cystic fibrosis. Mol Ther. 26(8):2034–2046.
   PubMed Web of Science ®Google Scholar
• Rodríguez Gascón A, del Pozo-Rodríguez A, Ángeles Solinís M, 2013. Non-viral delivery systems in gene therapy. In: Martin Molina F, editor. Gene therapy – tools and potential applications. Rijeka: InTechOpen.
   Google Scholar
• Rodriguez P, Harada T, Christian D, Pantano D, Tsai R, Discher D. 2013. Minimal "self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science. 339(6122):971–975.
   PubMed Web of Science ®Google Scholar
• Ruge C, Kirch J, Cañadas O, Schneider M, Perez-Gil J, Schaefer U, Casals C, Lehr C. 2011. Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine. 7(6):690–693.
   PubMed Web of Science ®Google Scholar
• Ruge C, Kirch J, Lehr C. 2013. Pulmonary drug delivery: From generating aerosols to overcoming biological barriers – therapeutic possibilities and technological challenges. Lancet Respir Med. 1(5):402–413.
   PubMed Web of Science ®Google Scholar
• Saad M, Garbuzenko O, Minko T. 2008. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine. 3(6):761–776.
   PubMed Web of Science ®Google Scholar
• Schlosser K, Taha M, Stewart D. 2018. Systematic assessment of strategies for lung-targeted delivery of microRNA mimics. Theranostics. 8(5):1213–1226.
   PubMed Web of Science ®Google Scholar
• Semple S, Akinc A, Chen J, Sandhu A, Mui B, Cho C, Sah D, Stebbing D, Crosley E, Yaworski E, et al. 2010. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol. 28(2):172–176.
   PubMed Web of Science ®Google Scholar
• Shao Z, Shao J, Tan B, Guan S, Liu Z, Zhao Z, He F, Zhao J. 2015. Targeted lung cancer therapy: Preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anti-cancer drugs and DNA. Intl. J. Nanomed. 10:1223–1233.
   PubMed Web of Science ®Google Scholar
• Sharma G, Valenta D, Altman Y, Harvey S, Xie H, Mitragotri S, Smith J. 2010. Polymer particle shape independently influences binding and internalization by macrophages. J Control Release. 147(3):408–412.
   PubMed Web of Science ®Google Scholar
• Shen C, Li J, Zhang Y, Li Y, Shen G, Zhu J, Tao J. 2017. Polyethylenimine-based micro/nanoparticles as vaccine adjuvants. Int J Nanomedicine. 12:5443–5460.
   PubMed Web of Science ®Google Scholar
• Sheppard N, Brinckmann S, Gartlan K, Puthia M, Svanborg C, Krashias G, Eisenbarth S, Flavell R, Sattentau Q, Wegmann F. 2014. Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens. Int Immunol. 26(10):531–538.
   PubMed Web of Science ®Google Scholar
• Sherman M, William L, Sobczyk M, Michaels S, Saifer M. 2012. Role of the methoxy group in immune responses to mPEG-protein conjugates. Bioconjug Chem. 23(3):485–499.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Abu Lila A, Fujita R, Awata M, Kawanishi M, Hashimoto Y, Okuhira K, Ishima Y, Ishida T. 2018. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes. Eur J Pharm Biopharm. 127:142–149.
   PubMed Web of Science ®Google Scholar
• Sosnowski T. 2015. Nanosized and nanostructured particles in pulmonary drug delivery. J Nanosci Nanotechnol. 15(5):3476–3487.
   PubMed Web of Science ®Google Scholar
• Stahl M, Schupp J, Jager B, Schmid M, Zissel G, Müller-Quernheim J, Prasse A. 2013. Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation. PLoS One. 8(11):e81382
   PubMed Web of Science ®Google Scholar
• Strong P, Ito K, Murray J, Rapeport G. 2018. Current approaches to the discovery of novel inhaled medicines. Drug Discov Today. 23(10):1705–1717.
   PubMed Web of Science ®Google Scholar
• Sung J, Pulliam B, Edwards D. 2007. Nanoparticles for drug delivery to the lungs. Trends Biotechnol. 25(12):563–570.
   PubMed Web of Science ®Google Scholar
• Szebeni J, Moghimi S. 2009. Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions. J Liposome Res. 19(2):85–90.
   PubMed Web of Science ®Google Scholar
• Taratula O, Kuzmov A, Shah M, Garbuzenko O, Minko T. 2013. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anti-cancer drugs and siRNA. J Control Release. 171(3):349–357.
   PubMed Web of Science ®Google Scholar
• Tehrani A, Hwang S, Kim T, Cho C, Hua J, Nah W, Kwon J, Kim J, Chang S, Yu K, et al. 2007. Aerosol delivery of Akt controls protein translation in the lungs of dual luciferase reporter mice. Gene Ther. 14(5):451–458.
   PubMed Web of Science ®Google Scholar
• Thanki K, Blum K, Thakur A, Rose F, Foged C. 2018. Formulation of RNA interference-based drugs for pulmonary delivery: Challenges and opportunities. Ther Deliv. 9(10):731–749.
   PubMed Web of Science ®Google Scholar
• Thess A, Grund S, Mui B, Hope M, Baumhof P, Fotin-Mleczek M, Schlake T. 2015. Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals. Mol Ther. 23(9):1456–1464.
   PubMed Web of Science ®Google Scholar
• Thorp E, Boada C, Jarbath C, Luo X. 2020. Nanoparticle platforms for antigen-specific immune tolerance. Front Immunol. 11:945.
   PubMed Web of Science ®Google Scholar
• Trapnell B, Whitsett J. 2002. GM-CSF Regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol. 64:775–802.
   PubMed Web of Science ®Google Scholar
• Vlahos R, Bozinovski S. 2014. Role of alveolar macrophages in chronic obstructive pulmonary disease. Front Immunol. 5:435
   PubMed Web of Science ®Google Scholar
• Walkey C, Olsen J, Guo H, Emili A, Chan W. 2012. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc. 134(4):2139–2147.
   PubMed Web of Science ®Google Scholar
• Weber S, Zimmer A, Pardeike J. 2014. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art. Eur J Pharm Biopharm. 86(1):7–22.
   PubMed Web of Science ®Google Scholar
• Wibroe P, Anselmo A, Nilsson P, Sarode A, Gupta V, Urbanics R, Szebeni J, Hunter A, Mitragotri S, Mollnes T, et al. 2017. Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nat Nanotechnol. 12(6):589–594.
   PubMed Web of Science ®Google Scholar
• Wittrup A, Ai A, Liu X, Hamar P, Trifonova R, Charisse K, Manoharan M, Kirchhausen T, Lieberman J. 2015. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat Biotechnol. 33(8):870–876.
   PubMed Web of Science ®Google Scholar
• Wuyts W, Agostini C, Antoniou K, Bouros D, Chambers R, Cottin V, Egan J, Lambrecht B, Lories R, Parfrey H, et al. 2013. The pathogenesis of pulmonary fibrosis: A moving target. Eur Respir J. 41(5):1207–1218.
   PubMed Web of Science ®Google Scholar
• Xu C, Jere D, Jin H, Chang S, Chung Y, Shin J, Kim J, Park S, Lee Y, Chae C, et al. 2008. Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. Am J Respir Crit Care Med. 178(1):60–73.
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Eeden S. 2018. Lung macrophage phenotypes and functional responses: Role in the pathogenesis of COPD. IJMS. 19(2):582.
   Google Scholar
• Yan Y, Liu L, Xiong H, Miller J, Zhou K, Kos P, Huffman K, Elkassih S, Norman J, Carstens R, et al. 2016. Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells. Proc Natl Acad Sci U S A. 113(39):E5702–5710.
   PubMed Web of Science ®Google Scholar
• Yanez Arteta M, Kjellman T, Bartesaghi S, Wallin S, Wu X, Kvist A, Dabkowska A, Székely N, Radulescu A, Bergenholtz J, et al. 2018. Successful re-programming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Proc Natl Acad Sci U S A. 115(15):E3351–3360.
   PubMed Web of Science ®Google Scholar
• Yin H, Kanasty R, Eltoukhy A, Vegas A, Dorkin J, Anderson D. 2014. Non-viral vectors for gene-based therapy. Nat Rev Genet. 15(8):541–555.
   PubMed Web of Science ®Google Scholar
• Yong T, Zhang X, Bie N, Zhang H, Zhang X, Li F, Hakeem A, Hu J, Gan L, Santos H, et al. 2019. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun. 10(1):3838.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Huang L. 2014. Lipid nanoparticles for gene delivery. Adv Genet. 88:13–36.
   PubMed Web of Science ®Google Scholar
• Zhao J, Stenzel M. 2018. Entry of nanoparticles into cells: The importance of nanoparticle properties. Polym Chem. 9(3):259–272.
   Web of Science ®Google Scholar
• Zhou Q, Leung S, Tang P, Parumasivam T, Loh Z, Chan H. 2015. Inhaled formulations and pulmonary drug delivery systems for respiratory infections. Adv Drug Deliv Rev. 85:83–99.
   PubMed Web of Science ®Google Scholar